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Abstract
In an editorial published in this journal, Baltussen et al argue that information on cost-effectiveness is not sufficient 
for priority setting for universal health coverage (UHC), a claim which is correct as far as it goes. However, their 
focus on the procedural legitimacy of ‘micro’ priority setting processes (eg, decisions concerning the reimbursement 
of specific interventions), and their related assumption that values for priority setting are determined only at this 
level, leads them to ignore the relevance of higher level, ‘macro’ priority setting processes, for example, consultations 
held by World Health Organization (WHO) Member States and other global stakeholders that have resulted in 
widespread consensus on the principles of UHC. Priority setting is not merely about discrete choices, nor should 
the focus be exclusively (or even mainly) on improving the procedural elements of micro priority setting processes. 
Systemic activities that shape the health system environment, such as strategic planning, as well as the substantive 
content of global policy instruments, are critical elements for priority setting for UHC. 
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While we endorse the call in the editorial by Baltussen et al1 for evidence-informed deliberative processes in priority setting for universal health coverage 
(UHC), we believe that the authors have unnecessarily 
confused certain questions while leaving others unnecessarily 
open. To structure our argument, we begin by formulating 
three specific propositions that we believe are explicit (or 
implicit) in the editorial:
1.	 International efforts to assist priority setting in health2,3 
focus (mainly and unduly) on the provision of cost-
effectiveness information (p. 1); 
2.	 Cost-effectiveness information (alone) does not 
adequately support countries to make choices about 
priorities (p. 1); and 
3.	 Priority setting is … a “value-laden political process, in 
which multiple criteria … are important and [in which] 
stakeholders often justifiably disagree about their relative 
importance” (p. 1). 
Leaving aside here a detailed discussion of DCP3 (which 
we nevertheless mention in passing later on), and focusing 
primarily on World Health Organization’s (WHO’s) role, in 
the first proposition Baltussen et al seem to be restricting 
their attention only to “WHO-CHOICE”4 (which is a 
programme of the WHO Secretariat initiated precisely for 
the purpose of making available high-quality, internationally 
comparable information on cost-effectiveness), while 
neglecting the broader scope of WHO’s policies, guidance, 
recommendations, and programmes related to priority setting 
in health. To the extent that Baltussen et al subscribe to the 
first proposition, in our view they would be making the error 
of conflating technical methods (such as WHO-CHOICE), 
which contribute to the evidence base for priority setting, 
with the values and principles underpinning a priority setting 
process. 
If on the other hand they do not subscribe to this view, 
they nevertheless seem to be criticizing a cost-effectiveness 
programme for producing cost-effectiveness information. 
The second proposition, therefore, amounts to the assertion 
that the provision of information on cost-effectiveness (which 
is an acknowledged international public good) is somehow 
equivalent to a recommendation that only cost-effectiveness 
information is relevant for priority setting. This proposition, 
if adhered to by Baltussen et al, would constitute a serious 
misunderstanding of the aims of WHO-CHOICE. 
This brings us to the third proposition, namely that priority 
setting involves “multiple criteria,” that it is “value laden,” and 
that “stakeholders often justifiably disagree.” In a related vein, 
the authors further observe that “society … has a wide range 
of social values,” and they argue that “the whole of these values 
should be considered when setting priorities.” 
The third proposition appears to us to be the most 
problematic, since, in this view, the content of the values 
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relevant for priority setting in health appears to be an open 
question: “stakeholders” with “diverging interests” engage in 
“pluralistic bargaining” to influence priority setting according 
to their particular “interests.” Taken to its logical conclusion, 
this proposition would suggest that – at least in an anarchy 
of values – legitimacy, reasonableness, and accountability can 
come only from widespread acceptability of the procedural 
features of social bargaining. While we do not suspect that 
Baltussen et al actually believe the extreme implications of 
this third proposition to be true, we nevertheless observe that 
– in their editorial at least – they have left that possibility far 
too open. 
Although we acknowledge that, at country level, priority 
setting processes involve a range of stakeholders with different 
views, with regard to global level policy formulated by WHO’s 
Member States, it must be recalled that the relevant values enjoy 
both broad consensus and an international mandate. So, while 
we agree with the need for an “evidence-informed deliberative 
process,” such as the authors recommend (especially for 
generating legitimacy at the relevant decision-making level in 
a given country), we believe that Baltussen et al have been too 
agnostic in their editorial about the criteria and values already 
embodied in UHC (that is, about the substance of UHC). The 
substance of UHC has been progressively defined and clarified 
by the Member States of the WHO, as well as by those of the 
United Nations (UN), in a voluminous series of resolutions, 
reports, and technical documents.5-9 Recently, UHC has been 
adopted as UN Sustainable Development Goal Target 3.8.10 
We observe, therefore, in contrast to the apparent agnosticism 
of Baltussen et al, that these international agreements contain 
numerous positive assertions concerning the substance and 
values of priority setting in health. 
For example, three main indicators have been identified 
within the UHC framework:
1.	 Coverage: How many people of those who would stand to 
benefit are receiving needed health services?
2.	 Financial risk protection: Are people put at risk of 
impoverishment, or of not accessing health services, 
because of out-of-pocket payments?
3.	 Equity: Is access to health services (and the financial 
impact of paying for them) equitably distributed across 
population groups?11 
While not exhaustive, these indicators nevertheless constitute 
a minimum set of criteria that represent the values that 
Member States of WHO (and of the UN) have endorsed 
through the organs of governance which have been instituted 
to determine policy on these matters. In light of the lengthy, 
participative, transparent, and mandated processes leading to 
the development of policies on UHC, in our view the above 
indicators can be held to constitute three ‘essential pillars’ for 
priority setting in the context of UHC: that is, other values 
can be added, but it would be a clear distortion of UHC to 
ignore any of these three. Thus, we conclude that priority 
setting for UHC does not start with a blank slate, nor is UHC 
an empty slogan or a catch-all phrase whose content is to be 
supplied solely through improved (procedural) rules for social 
bargaining; in fact, the essential content and values required 
by UHC are articulated in the relevant policies.
To return to what we have identified as the first and second 
propositions, above, an exclusive focus on WHO-CHOICE (or 
on DCP3, for that matter) in evaluating international efforts 
on priority setting is, therefore, incorrect. Furthermore, we 
note that DCP3 in fact emphasizes methods (called Extended 
Cost-Effectiveness Analysis) for operationalizing the triple 
values of health maximization, financial risk protection, and 
equity for priority setting in health – values corresponding 
precisely to the UHC indicators mentioned above. 
For these same reasons, we would like to reiterate that, at 
global-policy level and as formulated by the authorized 
representatives of WHO Member States, there has been 
an unprecedented amount of agreement on UHC policy, a 
policy which has itself been shaped through an “evidence-
informed deliberative process.” Baltussen et al come closest to 
acknowledging the centrality of UHC in priority setting when 
they write, 
“In its report Making fair choices on the path to UHC, 
[a consultative group appointed to advise] the WHO 
recently proposed the use of ‘cost-effectiveness,’ ‘priority to 
the worse off,’ and ‘financial protection’ as the three most 
essential criteria for countries to consider when setting 
priorities12 We consider these as ‘core’ criteria, representing 
social values for which there is broad consensus on their 
importance and which are of generic relevance across 
countries, disease areas and health interventions. Their 
identification can be seen as the product of international 
learning, particularly in academic circles, on priority 
setting.”13
However, we would add that the criteria referred to in the 
cited report are not merely the reflections of “academic 
learning,” nor are they values for which there is simply “broad 
consensus.” These criteria are in fact those that are embedded 
de jure in the core of UHC policy, a policy which has been 
adopted by WHO Member States and integrated in the 
framework of the Sustainable Development Goals.
Furthermore, whereas Baltussen et al stress priority setting 
in the context of decisions to reimburse specific healthcare 
interventions, in genuinely organizing health-system 
priorities around the goals of UHC, some of the required 
activities thus identified will almost certainly be systemic 
in nature, such as ‘improving health-system governance,’ 
‘ensuring equitable access to quality services,’ ‘separating 
prescribing from dispensing,’ or ‘setting up a pooled funding 
mechanism to purchase services.’ None of these system-wide 
activities are explicitly mentioned by Baltussen et al, although 
they are arguably instrumental for achieving UHC and 
might accordingly be given higher priority than decisions, 
for example, about the introduction of specific services to 
the benefit package. As a further example, in considering the 
systemic aspects of priority setting, one should equally take 
into account other activities not mentioned in the editorial, 
including health-sector situation analysis, national health 
strategic-plan development, and health-sector reviews, 
which comprise an inter-related set of activities that strongly 
influence the operating environment of discrete decision-
making. 
This brings us to the claim made by Baltussen et al, to the effect 
that evidence-informed, deliberative processes in support 
of priority setting have been mainly “theoretical.” In fact, a 
substantial portion of the WHO Secretariat’s ongoing work on 
priority setting is organized around routine strategic-planning 
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activities such as those just mentioned. In this context, country 
actors and stakeholders are already convening consultative 
groups for the sake of obtaining consensus on issues of 
concern. National health-strategy development, health-sector 
mid-term reviews, and joint annual health-sector reviews are 
being routinely conducted, and arguably constitute “evidence-
informed deliberative processes” of just the kind called for in 
the editorial. Supporting Member States to manage effectively 
such routine, regular, and periodic ‘priority setting processes’ 
(albeit by another name) is an ongoing area of activity for 
the WHO Secretariat, although we acknowledge that such 
activities could be further strengthened and supported. 
Finally, Baltussen et al highlight the role of health technology 
assessment (HTA) agencies in priority setting for discrete 
choices, such as for reimbursement via inclusion in a benefit 
package. In the light of recent policies established by WHO 
Member States,14 HTA is becoming a fast growing area of work 
within the WHO Secretariat. In WHO’s conception of HTA, a 
conception informed by global learning drawn from a variety 
of approaches, HTA brings together the work of a multi-
disciplinary group of experts, including health economists, 
legal advisors, pharmacists, epidemiologists, ethicists, 
medical engineers and health systems governance specialists. 
This responds, at least in part, to another important question 
left open by Baltussen et al: who should be invited to the 
deliberative dialogue? 
In the relevant WHO policies, HTA is not viewed as a 
technocratic solution to decision-making, nor as one focused 
on cost-effectiveness analysis, but rather as a transparent 
and fair evidence-informed decision-making process 
underpinned by a strong legal framework. With such a vision, 
provided the content of UHC policy is understood to be at the 
forefront, and the systemic elements of priority setting receive 
appropriate emphasis, we believe we can unreservedly find 
common cause with the proposals of Baltussen et al. 
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